T cells, innate-like lymphocytes bridging innate and adaptive immunity, play pivotal roles in tissue homeostasis, inflammation, and immunity through cytokine production and cytotoxicity
Once a stable maintenance dose is reached and lab values normalize, testing is typically performed every six months
Special medical attention is important, among other things, in cases of: existing gastrointestinal conditions type 2 diabetes or other metabolic disorders cardiovascular disease or increased cardiovascular risk regular use of other medications previous intolerance to GLP-1 or GIP/GLP-1 medications unclear symptoms before starting treatment pregnancy, breastfeeding, or plans to become pregnant Patients can find more information about the tolerability of established GLP-1 medications, for example, on our page about side effects of Wegovy with semaglutide
For example, using in vitro cultures, Zhou et al
As demand for weight-loss drugs rises, states grapple with Medicaid coverage Some researchers question long-term cost savings for state programs